Antigen-specific immunotherapy for MOG antibody-associated diseases.
作者信息
Nessler Stefan
机构信息
Institute of Neuropathology, University Medicine Göttingen, Göttingen, Germany.
出版信息
EBioMedicine. 2019 Oct;48:18-19. doi: 10.1016/j.ebiom.2019.09.029. Epub 2019 Oct 4.
Abstract
摘要
相似文献
1
Antigen-specific immunotherapy for MOG antibody-associated diseases.
EBioMedicine. 2019 Oct;48:18-19. doi: 10.1016/j.ebiom.2019.09.029. Epub 2019 Oct 4.
2
Perivascular enhancement in anti-MOG antibody demyelinating disease of the CNS.
J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):111-112. doi: 10.1136/jnnp-2018-319235. Epub 2018 Oct 8.
3
E.U. paediatric MOG consortium consensus: Part 3 - Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
Eur J Paediatr Neurol. 2020 Nov;29:22-31. doi: 10.1016/j.ejpn.2020.11.001. Epub 2020 Nov 7.
4
MOG antibody-associated encephalomyelitis/encephalitis.
Mult Scler. 2019 Oct;25(11):1427-1433. doi: 10.1177/1352458519837705. Epub 2019 Mar 25.
5
MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?
Mult Scler Relat Disord. 2019 Aug;33:67-69. doi: 10.1016/j.msard.2019.05.021. Epub 2019 May 28.
6
Do Myelin Oligodendrocyte Glycoprotein Antibodies Represent a Distinct Syndrome?
J Neuroophthalmol. 2019 Sep;39(3):416-423. doi: 10.1097/WNO.0000000000000779.
7
A Stroke Mimic: Anti-MOG Antibody-Associated Disorder Presenting as Acute Hemiparesis.
Pediatr Neurol. 2020 Jul;108:123-125. doi: 10.1016/j.pediatrneurol.2020.02.009. Epub 2020 Apr 12.
8
MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis.
Mult Scler Relat Disord. 2019 May;30:48-50. doi: 10.1016/j.msard.2019.01.053. Epub 2019 Feb 2.
9
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Demyelination Comorbid With Leber Hereditary Optic Neuropathy.
JAMA Neurol. 2019 Feb 1;76(2):227-228. doi: 10.1001/jamaneurol.2018.3207.
10
Recurrent visual loss in a 64-year-old man.
Pract Neurol. 2020 Apr;20(2):175-178. doi: 10.1136/practneurol-2019-002404. Epub 2019 Oct 24.
本文引用的文献
1
Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques.
EBioMedicine. 2019 Sep;47:492-505. doi: 10.1016/j.ebiom.2019.08.052. Epub 2019 Sep 3.
2
Signaling Cascade through DC-ASGPR Induces Transcriptionally Active CREB for IL-10 Induction and Immune Regulation.
J Immunol. 2019 Jul 15;203(2):389-399. doi: 10.4049/jimmunol.1900289. Epub 2019 Jun 7.
3
Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10).
Cell Mol Immunol. 2020 Jan;17(1):95-107. doi: 10.1038/s41423-019-0218-0. Epub 2019 Mar 6.
4
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
JAMA Neurol. 2018 Apr 1;75(4):478-487. doi: 10.1001/jamaneurol.2017.4601.
5
Clinical presentation and prognosis in MOG-antibody disease: a UK study.
Brain. 2017 Dec 1;140(12):3128-3138. doi: 10.1093/brain/awx276.
6
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
J Neuroinflammation. 2016 Sep 27;13(1):280. doi: 10.1186/s12974-016-0718-0.
7
Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
Mult Scler. 2016 Dec;22(14):1821-1829. doi: 10.1177/1352458516631038. Epub 2016 Feb 11.
8
Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells.
J Exp Med. 2012 Jan 16;209(1):109-21. doi: 10.1084/jem.20110399. Epub 2012 Jan 2.
9
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
N Engl J Med. 2008 Feb 14;358(7):676-88. doi: 10.1056/NEJMoa0706383.
Zotero 插件